Status
Conditions
Treatments
About
The European Union's Horizon 2020 project issued a Call for Action [1] in December 2013 to design, develop, disseminate and evaluate new IT technologies for use in integrative treatment processes, with emphasis on complex adult patient. Assuta Hospital submitted a proposal for this call, as part of a broad consortium of 10 participants from various European countries.
The CONNECARE consortium has formulated a general model for integrative treatment, and is currently in the technological development stages, to create a smart (supportive decision) and adaptive system that supports integrative treatment processes both in the hospital and in the community for personalized treatment in complex chronic patients. The development includes a significant integrative component of self-care management by the patient and / or the primary caregiver.
Following the completion of the technological development, clinical trials will be held in four organizations throughout Europe - Assuta Hospital in Ashdod in cooperation with the Maccabi community in Ashdod, two centers in Catalonia and the Groningen region in the Netherlands. The purpose of the studies is to assess the impact of the implementation of the model, processes and digital tools that will be built during the project.
Full description
The intervention in this study consists of two parts:
The study protocol:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All Maccabi members who arrive at the ER in an unplanned manner
Age over 65
Living in a home and not in a nursing home
LACE> 7
At least three of the following conditions:
The patient and / or the main caregiver speak Hebrew, English or Russian
The patient or primary caregiver has a password to the Maccabi Online website
The patient and / or the primary caregiver have basic technological knowledge in the use of the applications
The patient has wireless Internet access at home (via Wifi or through a cellular connection)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
220 participants in 2 patient groups
Loading...
Central trial contact
Reut Ron, M.SC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal